Collaborative Practice provides a forum for healthcare professionals to share expertise and enhance communication.
Undertreatment of pain, or oligoanalgesia, is a serious worldwide problem in the pediatric setting (Alexander & Manno, 2003; Lander, 1990; Rupp & Delaney, 2004;
Marks and Sachar's historic study (1973) first brought light to the problem of poor pain management, implicating the lack of pharmacologic information, misunderstanding about addiction and its prevalence, or even "puritanical counter-reactions" about prescribing a drug that could cause euphoria as some of the root causes. These same problems exist today and are unfortunately compounded by stereotyping based on cause of pain, race, culture, gender, socioeconomic status, age, lack of parental understanding of the pros and cons of pain medication, and lifestyle (Elander, Lusher, Bevan, & Telfer, 2003; Goldfrank & Knopp, 2000; Hostetler, Auinger, & Szilagyi, 2002; Rupp & Delaney, 2004; Stimmel, 1989).
Despite the overwhelming evidence to the contrary, many physicians cite fear of addiction as their primary reason for not prescribing additional opioids when their patient complains of pain (Fishbain, Rosomoff, & Rosomoff, 1992; Friedman, 1990; Lander, 1990; Portenoy, 1990; Rupp & Delaney, 2004; Schnoll & Weaver, 2003). As a result of this opiophobia (Furrow, 2001), many patients up the ante by displaying progressively worsening symptoms in an attempt to get the medication they need to feel relief. They may even resort to extreme behaviors they would have normally considered unconscionable had their pain been adequately controlled (Kirsh, Whitcomb, Donaghy, & Passik, 2002; Porter-Williamson, Heffernan, & von Gunten, 2003). This phenomenon, called pseudoaddiction, was first described in 1989 by Weissman and Haddox (1989) and is often misdiagnosed as a true addiction.